Clinical Trials Square

Focused Ultrasound Therapy

Focused ultrasound is an early-stage, non-invasive, therapeutic technology with the potential to improve the quality of life and decrease the cost of care for patients with chyluria. This novel technology focuses beams of ultrasonic energy precisely and accurately on targets deep in the body without damaging surrounding normal tissue. Where the beams converge, the ultrasound produces precise ablation (thermal destruction of tissue) enabling the aberrant lymphatic to urinary tract connections to be treated without surgery.

The primary options for treatment of chyluria include embolization or invasive surgery.

For certain patients, focused ultrasound could provide a non-invasive alternative to surgery with less risk of complications and lower cost.


  • Focused ultrasound is non-invasive, so it does not carry added concerns like surgical wound healing or infection.
  • It can be repeated, if necessary.

Clinical Trials

At the present time, there are no clinical trials recruiting patients for focused ultrasound treatments for chyluria.

Regulatory Approval and Reimbursement

Focused ultrasound treatment for chyluria is not yet approved by regulatory bodies or covered by medical insurance companies.

Notable Papers

Xiao J, Sun T, Zhang S, et al. HIFU, a noninvasive and effective treatment for chyluria: 15 years of experience. Surg Endosc. December 2017. doi:10.1007/s00464-017-6017-8.

Click here for additional references from PubMed.


The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903